Pfizer (PFE)

Operating Cash Flow Growth

-11.76%

TTM · Period ending:

PFE logo

PFE Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-11.76%
PFE TTM Cash from Operations YoY % (-1.50% → -11.76%)
High-resolution chart · PNG

PFE operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Pfizer Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
132.4793%
63.6428%
102.716%
52.0013%
37.1672%
57.36%
4.336%
58.4915%
67.8784%
83.4694%
79.8036%
4.4885%
-16.9718%
-30.4307%
-21.1901%
-2.5829%
12.5654%
42.3279%
13.4841%
19.3591%
9.8305%
-17.568%
22.3648%
-2.3468%
1.8822%
21.9529%
17.8543%
80.2585%
83.6653%
81.336%
56.5056%
13.964%
19.0191%
2.466%
-4.79%
-7.0289%
-12.6294%
-3.7073%
-1.4991%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.